SEC Charges Three Ex-Biopharmaceutical Company Executives With Scheme to Mislead About Cancer Drug Application
March 13, 2025
March 13, 2025
WASHINGTON, March 13 -- The Securities and Exchange Commission issued the following litigation release (No. 1:25-cv-10599; D. Mass. filed Mar. 12, 2025) involving Stefano R. Carchedi, Marie L. Foegh Ramwell and James G. Cullem:
* * *
The Securities and Exchange Commission today filed charges against Stefano R. Carchedi, Marie L. Foegh Ramwell, and James G. Cullem--the former chief executive officer, chief medical officer, and chief business officer of Massachusetts-base . . .
* * *
The Securities and Exchange Commission today filed charges against Stefano R. Carchedi, Marie L. Foegh Ramwell, and James G. Cullem--the former chief executive officer, chief medical officer, and chief business officer of Massachusetts-base . . .